1
|
Domínguez-Jurado E, Ripoll C, Lara-Sánchez A, Ocaña A, Vitórica-Yrezábal IJ, Bravo I, Alonso-Moreno C. Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy. J Inorg Biochem 2024; 253:112486. [PMID: 38266323 DOI: 10.1016/j.jinorgbio.2024.112486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2023] [Revised: 01/14/2024] [Accepted: 01/15/2024] [Indexed: 01/26/2024]
Abstract
The modular synthesis of the heteroscorpionate core is explored as a tool for the rapid development of ruthenium-based therapeutic agents. Starting with a series of structurally diverse alcohol-NN ligands, a family of heteroscorpionate-based ruthenium derivatives was synthesized, characterized, and evaluated as an alternative to platinum therapy for breast cancer therapy. In vitro, the antitumoral activity of the novel derivatives was assessed in a series of breast cancer cell lines using UNICAM-1 and cisplatin as metallodrug control. Through this approach, a bimetallic heteroscorpionate-based metallodrug (RUSCO-2) was identified as the lead compound of the series with an IC50 value range as low as 3-5 μM. Notably, RUSCO-2 was found to be highly cytotoxic in TNBC cell lines, suggesting a mode of action independent of the receptor status of the cells. As a proof of concept and taking advantage of the luminescent properties of one of the complexes obtained, uptake was monitored in human breast cancer MCF7 cell lines by fluorescence lifetime imaging microscopy (FLIM) to reveal that the compound is evenly distributed in the cytoplasm and that the incorporation of the heteroscorpionate ligand protects it from aqueous processes, conversion in another entity, or the loss of the chloride group. Finally, ROS studies were conducted, lipophilicity was estimated, the chloride/water exchange was studied, and stability studies in simulated biological media were carried out to propose structure-activity relationships.
Collapse
Affiliation(s)
- Elena Domínguez-Jurado
- Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Ciencias y Tecnologías Químicas-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Ciudad Real 13071, Spain
| | - Consuelo Ripoll
- Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Física. Facultad de Farmacia de Albacete, Albacete 02071, Spain
| | - Agustín Lara-Sánchez
- Universidad de Castilla-La Mancha, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Ciencias y Tecnologías Químicas-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Ciudad Real 13071, Spain
| | - Alberto Ocaña
- Experimental Therapeutics Unit, Hospital clínico San Carlos, IdISSC and CIBERONC, Madrid, Spain
| | - Iñigo J Vitórica-Yrezábal
- Departamento de Química Inorgánica, Facultad de Ciencias, Universidad de Granada, Avda de Fuentenueva. s/n, 18071 Granada, Spain
| | - Iván Bravo
- Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Física. Facultad de Farmacia de Albacete, Albacete 02071, Spain
| | - Carlos Alonso-Moreno
- Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Ciencias y Tecnologías Químicas-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Ciudad Real 13071, Spain.
| |
Collapse
|
2
|
del Campo-Balguerías A, Parra-Cadenas B, Nieto-Jimenez C, Bravo I, Ripoll C, Poyatos-Racionero E, Gancarski P, Carrillo-Hermosilla F, Alonso-Moreno C, Ocaña A. Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents. Int J Mol Sci 2023; 24:13820. [PMID: 37762123 PMCID: PMC10530677 DOI: 10.3390/ijms241813820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Revised: 08/29/2023] [Accepted: 09/03/2023] [Indexed: 09/29/2023] Open
Abstract
The modular synthesis of the guanidine core by guanylation reactions using commercially available ZnEt2 as a catalyst has been exploited as a tool for the rapid development of antitumoral guanidine candidates. Therefore, a series of phenyl-guanidines were straightforwardly obtained in very high yields. From the in vitro assessment of the antitumoral activity of such structurally diverse guanidines, the guanidine termed ACB3 has been identified as the lead compound of the series. Several biological assays, an estimation of AMDE values, and an uptake study using Fluorescence Lifetime Imaging Microscopy were conducted to gain insight into the mechanism of action. Cell death apoptosis, induction of cell cycle arrest, and reduction in cell adhesion and colony formation have been demonstrated for the lead compound in the series. In this work, and as a proof of concept, we discuss the potential of the catalytic guanylation reactions for high-throughput testing and the rational design of guanidine-based cancer therapeutic agents.
Collapse
Affiliation(s)
- Almudena del Campo-Balguerías
- Unidad nanoDrug, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02008 Albacete, Spain; (A.d.C.-B.); (I.B.); (C.R.)
- Departamento Química Inorgánica, Orgánica y Bioquímica, Facultad de Farmacia de Albacete-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, 02008 Albacete, Spain
| | - Blanca Parra-Cadenas
- Departamento de Química Inorgánica, Orgánica y Bioquímica-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain; (B.P.-C.); (F.C.-H.)
| | - Cristina Nieto-Jimenez
- Experimental Therapeutics Unit, Hospital Clínico San Carlos, IdISSC, Fundación Jiménez Díaz, START, 28040 Madrid, Spain
| | - Iván Bravo
- Unidad nanoDrug, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02008 Albacete, Spain; (A.d.C.-B.); (I.B.); (C.R.)
- Departamento Química-Física, Facultad de Farmacia de Albacete, Universidad de Castilla-La Mancha, 02008 Albacete, Spain
| | - Consuelo Ripoll
- Unidad nanoDrug, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02008 Albacete, Spain; (A.d.C.-B.); (I.B.); (C.R.)
- Departamento Química-Física, Facultad de Farmacia de Albacete, Universidad de Castilla-La Mancha, 02008 Albacete, Spain
| | | | - Pawel Gancarski
- Cancerappy, Avda Ribera De Axpe, 28, 48950 Erandio, Spain; (E.P.-R.); (P.G.)
| | - Fernando Carrillo-Hermosilla
- Departamento de Química Inorgánica, Orgánica y Bioquímica-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain; (B.P.-C.); (F.C.-H.)
| | - Carlos Alonso-Moreno
- Unidad nanoDrug, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, 02008 Albacete, Spain; (A.d.C.-B.); (I.B.); (C.R.)
- Departamento Química Inorgánica, Orgánica y Bioquímica, Facultad de Farmacia de Albacete-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, 02008 Albacete, Spain
| | - Alberto Ocaña
- Experimental Therapeutics Unit, Hospital Clínico San Carlos, IdISSC, Fundación Jiménez Díaz, START, 28040 Madrid, Spain
| |
Collapse
|
3
|
Mehdipour M, Dehghan G, Yekta R, Hanifeh Ahagh M, Mahdavi M, Ghasemi Z, Fathi Z. DNA-binding affinity, cytotoxicity, apoptosis, cell cycle inhibition and molecular docking studies of a new stilbene derivative. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS 2019; 38:101-118. [PMID: 30931800 DOI: 10.1080/15257770.2018.1498517] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Stilbene derivatives have been found to possess promising anticancer activities against human cancer cell lines in vitro. In the present study, we have investigated cytotoxic, apoptosis induction and DNA binding activity of new stilbene derivative, (E)-1-(4-Chlorophenyl)-4,5-diphenyl-2-[4-(4-methoxystryl)phenyl]-1H-imidazol (STIM) on K562 chronic myeloid leukemia cell line. Via MTT assay STIM demonstrated cytotoxic activity against K562 cell line with IC50 value of 150 µM. Apoptosis, as the mechanism of cell death, was evaluated by morphological study and flow cytometric analysis. In vitro DNA binding property of STIM has been studied by vital spectroscopic techniques, which indicated that STIM interact with ctDNA through groove binding mode and binding constant (Kb) was estimated to be 6.9 × 104 M-1. Docking studies revealed that hydrophobic is the most important interaction in STIM-DNA complex, and that the ligand (STIM) interacts with DNA via groove binding mode and the bindiyspng energy was calculated as -13.37 kcal/mol. Taken together, the present study suggests that STIM exhibits anticancer effect on K562 cell line through the induction of apoptosis as well as cell cycle arrest at Sub-G1 phase and also can bind to double helix DNA in vitro.
Collapse
Affiliation(s)
- Maryam Mehdipour
- a Department of Biology, Faculty of Natural Science s, University of Tabriz , Tabriz , Iran
| | - Gholamreza Dehghan
- a Department of Biology, Faculty of Natural Science s, University of Tabriz , Tabriz , Iran
| | - Reza Yekta
- a Department of Biology, Faculty of Natural Science s, University of Tabriz , Tabriz , Iran
| | - Mina Hanifeh Ahagh
- a Department of Biology, Faculty of Natural Science s, University of Tabriz , Tabriz , Iran
| | - Majid Mahdavi
- a Department of Biology, Faculty of Natural Science s, University of Tabriz , Tabriz , Iran
| | - Zarrin Ghasemi
- b Department of Organic Chemistry and Biochemistry, Faculty of Chemistry , University of Tabriz , Tabriz , Iran
| | - Zahra Fathi
- b Department of Organic Chemistry and Biochemistry, Faculty of Chemistry , University of Tabriz , Tabriz , Iran
| |
Collapse
|
4
|
Rahman A, O'Sullivan P, Rozas I. Recent developments in compounds acting in the DNA minor groove. MEDCHEMCOMM 2018; 10:26-40. [PMID: 30774852 DOI: 10.1039/c8md00425k] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Accepted: 12/11/2018] [Indexed: 12/12/2022]
Abstract
The macromolecule that carries genetic information, DNA, is considered as an exceptional target for diseases depending on cellular division of malignant cells (i.e. cancer), microbes (i.e. bacteria) or parasites (i.e. protozoa). To aim for a comprehensive review to cover all aspects related to DNA targeting would be an impossible task and, hence, the objective of the present review is to present, from a medicinal chemistry point of view, recent developments of compounds targeting the minor groove of DNA. Accordingly, we discuss the medicinal chemistry aspects of heterocyclic small-molecules binding the DNA minor groove, as novel anticancer, antibacterial and antiparasitic agents.
Collapse
Affiliation(s)
- Adeyemi Rahman
- School of Chemistry , Trinity Biomedical Sciences Institute , Trinity College Dublin , 152-160-Pearse Street , Dublin 2 , Ireland .
| | - Patrick O'Sullivan
- School of Chemistry , Trinity Biomedical Sciences Institute , Trinity College Dublin , 152-160-Pearse Street , Dublin 2 , Ireland .
| | - Isabel Rozas
- School of Chemistry , Trinity Biomedical Sciences Institute , Trinity College Dublin , 152-160-Pearse Street , Dublin 2 , Ireland .
| |
Collapse
|
5
|
Zhang HR, Liu YC, Chen ZF, Guo J, Peng YX, Liang H. Crystal Structures, Cytotoxicity, Cell Apoptosis Mechanism, and DNA Binding of Two 8-Hydroxylquinoline Zinc(II) Complexes. RUSS J COORD CHEM+ 2018. [DOI: 10.1134/s107032841805007x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
6
|
Posadas I, Alonso-Moreno C, Bravo I, Carrillo-Hermosilla F, Garzón A, Villaseca N, López-Solera I, Albaladejo J, Ceña V. Synthesis, characterization, DNA interactions and antiproliferative activity on glioblastoma of iminopyridine platinum(II) chelate complexes. J Inorg Biochem 2017; 168:46-54. [DOI: 10.1016/j.jinorgbio.2016.11.032] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2016] [Revised: 11/22/2016] [Accepted: 11/30/2016] [Indexed: 12/21/2022]
|
7
|
Broomfield LM, Alonso-Moreno C, Martin E, Shafir A, Posadas I, Ceña V, Castro-Osma JA. Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes. Dalton Trans 2017; 46:16113-16125. [DOI: 10.1039/c7dt03369a] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The potential utility of aminophosphine ligands in both high-throughput testing and rational design of new anticancer metallodrugs.
Collapse
Affiliation(s)
- L. M. Broomfield
- Institute of Chemical Research of Catalonia (ICIQ)
- Barcelona Institute of Science and Technology
- Tarragona
- Spain
| | - C. Alonso-Moreno
- Departamento de Química Inorgánica
- Orgánica y Bioquímica
- Facultad de Farmacia
- Universidad de Castilla-La Man-cha
- 02071-Albacete
| | - E. Martin
- Institute of Chemical Research of Catalonia (ICIQ)
- Barcelona Institute of Science and Technology
- Tarragona
- Spain
| | - A. Shafir
- Institute of Chemical Research of Catalonia (ICIQ)
- Barcelona Institute of Science and Technology
- Tarragona
- Spain
| | - I. Posadas
- CIBERNED
- Instituto de Salud Carlos III
- Madrid
- Spain
- Unidad Asociada Neurodeath CSIC-UCLM
| | - V. Ceña
- CIBERNED
- Instituto de Salud Carlos III
- Madrid
- Spain
- Unidad Asociada Neurodeath CSIC-UCLM
| | - J. A. Castro-Osma
- Departamento de Química Inorgánica
- Orgánica y Bioquímica
- Facultad de Farmacia
- Universidad de Castilla-La Man-cha
- 02071-Albacete
| |
Collapse
|